Novel Tetrasaccharides Isolated from Squid Cartilage Chondroitin Sulfate E Contain Unusual Sulfated Disaccharide Units GlcA(3-O-sulfate)beta 1-3GalNAc(6-O-sulfate) or GlcA(3-O-sulfate)beta 1-3GalNAc(4,6-O-disulfate)*

(Received for publication, March 26, 1997, and in revised form, May 15, 1997)

Akiko Kinoshita , Shuhei Yamada , Stuart M. Haslam Dagger , Howard R. Morris Dagger , Anne Dell Dagger and Kazuyuki Sugahara §

From the Department of Biochemistry, Kobe Pharmaceutical University, Higashinada-ku, Kobe 658, Japan and the Dagger  Department of Biochemistry, Imperial College, London SW7 2AZ, United Kingdom

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

We previously isolated novel tetrasaccharides containing 3-O-sulfated glucuronic acid from king crab cartilage chondroitin sulfate K and demonstrated that the disaccharide units containing 3-O-sulfated glucuronic acid were decomposed by chondroitinase ABC digestion (Sugahara, K., Tanaka, Y., Yamada, S., Seno, N., Kitagawa, H., Haslam, S. M., Morris, H. R., and Dell, A. (1996) J. Biol. Chem. 271, 26745-26754). The findings indicated the necessity to re-evaluate the disaccharide compositions of chondroitin sulfate preparations purified from other biological sources and analyzed using the above enzyme. In this study, to evaluate squid cartilage chondroitin sulfate E a series of even-numbered oligosaccharides were isolated after exhaustive digestion with sheep testicular hyaluronidase and subsequent fractionation by gel chromatography. The tetrasaccharide fraction was subfractionated by high performance liquid chromatography on an amine-bound silica column. Systematic structural analysis of five major fractions, h, l, m, n, and q, by fast atom bombardment mass spectrometry, enzymatic digestions in conjunction with capillary electrophoresis, and 500-MHz 1H NMR spectroscopy revealed one disulfated, three trisulfated, and one tetrasulfated tetrasaccharide structure: fraction h, GlcAbeta 1-3GalNAc(4S)beta 1-4GlcAbeta 1-3GalNAc(4S); fraction l, GlcA(3S)beta 1-3GalNAc(6S)beta 1-4GlcAbeta 1-3GalNAc(4S); fraction m, GlcA(3S)beta 1-3GalNAc(4S)beta 1-4GlcAbeta 1-3GalNAc(4S); fraction n, GlcAbeta 1-3GalNAc(4S,6S)beta 1-4GlcAbeta 1-3GalNAc(4S); and fraction q, GlcA(3S)beta 1-3GalNAc(4S,6S)beta 1-4GlcAbeta 1-3GalNAc(4S), where 3S, 4S, and 6S represent 3-O-, 4-O- and 6-O-sulfate, respectively. The structures found in fractions h and m as well as the unsaturated counterpart of that found in fraction n have been reported, whereas those in fractions l and q are novel in that they contained unusual disulfated and trisulfated disaccharide units where GlcA(3S) is directly linked to GalNAc(6S) and GalNAc(4S,6S), respectively. These novel tetrasaccharide sequences are distinct from those found in other chondroitin sulfate isoforms and may play key roles in the biological functions and activities of chondroitin sulfate E not only from squid cartilage but also from mammalian cells and tissues.


INTRODUCTION

Chondroitin sulfate (CS)1 proteoglycans are ubiquitous components of the extracellular matrix of connective tissues and are also found at the surface of many cell types and in intracellular secretory granules. They play several key roles in the normal physiology of animal tissues, regulating cell migration, cell recognition, and tissue morphogenesis (for reviews, see Refs. 1-3). Immunological studies using CS-specific antibodies have revealed the developmentally regulated expression of the epitopes in the rodent fetus and in the rat central nervous system (for reviews, see Refs. 4 and 5). Some CS epitopes are distributed differentially in distinct tissues and in functionally distinct domains within these tissues (6). These observations suggest that CS chains differing in degree and profile of sulfation perform distinct functions in development.

Oversulfated CS isoforms contain rare structural building units; thus, they may form domain structures that interact specifically with other molecules. Oversulfated CSs were originally discovered in cartilages of shark (7) and invertebrates such as squid and horseshoe crab (king crab) (Ref. 8; for a review, see Ref. 9). Oversulfated CS isoforms from the shark, squid, and horseshoe crab cartilage are characterized by the distinct disulfated disaccharide units, GlcA(2S)beta 1-3GalNAc(6S), GlcAbeta 1-3GalNAc(4S,6S), and GlcA(3S)beta 1-3GalNAc(4S), where 2S, 3S, 4S, and 6S represent 2-O-, 3-O-, 4-O-, and 6-O-sulfate and are designated as CS-D, CS-E, and CS-K, respectively (10-12). Oversulfated CSs are not limited to invertebrates or marine vertebrates and have been identified in various tissues and cells from higher land-dwelling vertebrates. CS-D and CS-E have been found in human rib cartilage in small proportions (13). Another disaccharide unit, IdceA-GalNAc(4S,6S), has also been identified in dermatan sulfate (DS) from hagfish notochord (14), mammalian liver (15), and bovine kidney (16). This type of DS is designated as DS-E in this article.

Although the specific physiological functions of oversulfated CS isoforms have not been clarified, they show differentiation-associated expression. Elevated CS-E synthesis has been observed in the terminal differentiation of embryonic chick chondrocytes (17). Oversulfated CS isoforms are differentiation markers for different mast cell (MC) subsets (Refs. 18 and 19; for a review, see Ref. 20). While heparin is found in the secretory granules of "connective tissue" type MC, as typified by the "serosal" MC (21), CS-E or DS-E is usually found in those of "mucosal" MC, "bone marrow-derived" MC, and related cells (22-26). A proposed role for secretory granule proteoglycans involves their concentration and the stabilization of secretory granule enzymes (27). Close association between histamine and CS-E proteoglycan release has also been observed in human colonic mucosa, which is assumed to contain mast cells (24). DS-E has been demonstrated in guinea pig peritoneal macrophages (28). Kolset et al. (29, 30) showed CS-E and DS-E in human monocyte-derived macrophages as well as CS-E or CS-D in mature peritoneal macrophages and suggested that CS-E could be a marker for differentiation of monocytes into macrophages. Recently, Edwards et al. (31) demonstrated that human macrophages exhibited the differentiation-associated expression of CS-E or DS-E, which bound to lipoprotein lipase, and hypothesized that the marked increase in the synthesis of the surface proteoglycans containing CS-E/DS-E increased the macrophage uptake of plasma low density lipoprotein, i.e. the atherogenic potential of these cells.

CS-E exhibits biological activities in vitro. An in vitro anticoagulant property has been reported for squid cartilage CS-E (32). This property is mediated primarily by acceleration of heparin cofactor II interaction with thrombin (33). Thrombomodulin, which is an integral membrane protein with anticoagulant activity, bears a single CS or DS chain with a unique GalNAc(4S,6S)beta 1-4GlcAbeta 1-3GalNAc(4S,6S) sequence of a CS-E type at the nonreducing terminus (34). The CS or DS chain is involved in its anticoagulant activity through direct binding to thrombin and through activating protein C (for a review, see Ref. 35). More recently, monocyte procoagulant activities of purified coagulation factors, VIIIa and IXa, were reported to be specifically inhibited on monocyte surfaces by size-defined CS-E oligosaccharides, indicating that the CS-E expressed on monocyte membranes inhibits factor X-activating reactions in the intrinsic pathway (36). Squid cartilage CS-E and murine bone marrow-derived MC CS-E (or DS-E) were noted to specifically inhibit the function of activated properdin in the alternative complement pathway (37). The former activates the contact (Hageman factor) system of plasma in vitro as does heparin (38).

In view of the importance of CS chains in various biological systems, we have been conducting systematic structural studies of various CS isoforms including CS-D, CS-E, and CS-K. Recent studies have revealed that the structural complexity and diversity of CS chains resulted from an extensive series of modifications by various sulfation reactions (39-43). Novel oligosaccharides that contained an unusual GlcA(3S) residue were isolated from CS-K of king crab cartilage (44, 45). To our surprise, when these oligosaccharides were digested with chondroitinase ABC, the resultant disaccharide units containing a GlcA(3S) residue were undetectable when monitored by UV-absorbance and were assumed to have been decomposed during the enzyme treatment. Thus, we reinvestigated squid cartilage CS-E that had been characterized by chondroitinase ABC digestion (11, 46) to see if it contained GlcA(3S).

In this study, five tetrasaccharides were isolated after digestion of a commercial squid cartilage CS-E preparation with hyaluronidase instead of chondroitinase ABC to prevent degradation of possible structures that may contain GlcA(3S) residues. The analysis by 500-MHz 1H NMR spectroscopy in conjunction with fast atom bombardment-mass spectrometry (FAB-MS) unambiguously demonstrated GlcA(3S) residues in some of the major tetrasaccharide components. Preliminary findings were reported in abstract form (47).


EXPERIMENTAL PROCEDURES

Materials

CS isoform preparations (super special grade), including squid cartilage CS-E, whale cartilage CS-A, shark cartilage CS-C, and shark cartilage CS-D, were purchased from Seikagaku Corp., Tokyo, Japan. A king crab cartilage CS-K peptide preparation (48) was a gift from the late Dr. N. Seno (Ochanomizu University, Tokyo). Six unsaturated standard CS disaccharides, chondroitinase ABC (EC 4.2.2.4), and AC-II (EC 4.2.2.5) were purchased from Seikagaku Corp.. Sheep testicular hyaluronidase (EC 3.2.1.35) was obtained from Sigma. Bio-Gel P-10 and Sephadex G-25 (fine) were obtained from Bio-Rad and Pharmacia Biotech Inc., respectively. 2-Aminoacridone (AMAC) and NaCNBH3 were obtained from LAMBDA Corp. (Graz, Austria) and Aldrich, respectively. The following tetrasaccharides were prepared from shark cartilage CS-D as described (41): GlcAbeta 1-3GalNAc(6S)beta 1-4GlcAbeta 1-3GalNAc(6S), GlcAbeta 1-3GalNAc(4S)beta 1-4GlcAbeta 1-3GalNAc(4S), GlcAbeta 1-3GalNAc(6S)beta 1-4GlcAbeta 1-3GalNAc(4S), GlcA(2S)beta 1-3GalNAc(6S)beta 1-4GlcAbeta 1-3GalNAc(6S), GlcAbeta 1-3Gal NAc(4S)beta 1-4GlcA(2S)beta 1-3GalNAc(6S), and GlcA(2S)beta 1-3GalNAc(6S)beta 1-4GlcAbeta 1-3GalNAc(4S). GlcA(3S)beta 1-3GalNAc(4S)beta 1-4GlcAbeta 1-3GalNAc(4S) and GlcA(3S)beta 1-3GalNAc(4S)beta 1-4GlcA(3S)beta 1-3Gal NAc(4S) were prepared from king crab cartilage as reported (44).

Chondroitinase ABC Digestion of Various CS Isoforms

Various CS isoform preparations (CS-A, CS-C, CS-D, CS-E, and CS-K) of 0.4 mg each were digested with 50 mIU of chondroitinase ABC in a total volume of 400 µl of Tris-HCl, pH 8.0, containing 0.06 M sodium acetate at 37 °C. At appropriate time intervals, a 10-µl aliquot of the incubation mixture was withdrawn and mixed with 0.01 M HCl to terminate the reaction. Unsaturated oligosaccharide products were determined to monitor the reaction by absorbance at 232 nm using the average millimolar absorption coefficient of 5.5. The digestion rate was calculated based on the amount of the resultant unsaturated oligosaccharides relative to the uronic acid value determined for each CS isoform by the carbazole reaction (49) (Fig. 1). Analysis of the chondroitinase ABC digest of CS-E was carried out by HPLC on an amine-bound silica PA03 column to determine the disaccharide composition as reported (50).


Fig. 1. Differential susceptibility of various CS isoforms to chondroitinase ABC. Various individual CS isoforms, CS-A, CS-C, CS-D, CS-E, and CS-K, were digested with chondroitinase ABC; aliquots of each digest were withdrawn at the indicated time intervals; and the unsaturated products formed by the eliminase action of the enzyme were estimated by absorption at 232 nm. The results are presented as percentages of the uronic acid recovered as unsaturated oligosaccharides relative to the total uronic acid.
[View Larger Version of this Image (23K GIF file)]

Preparation of Oligosaccharide Fractions

A commercial squid cartilage CS-E (100 mg) was digested with 10 mg (approximately 15,000 National formulary units) of sheep testicular hyaluronidase in a total volume of 2.0 ml of 50 mM sodium phosphate buffer, pH 6.0, containing 150 mM NaCl (1 National formulary unit corresponds to the amount of the enzyme which hydrolyzes 74 µg of hyaluronate/min) (51, 52). Digestion proceeded at 37 °C for 18 h, and then an additional 8 mg (6000 National formulary units) of the enzyme was added and the incubation was continued for 7 h to complete the digestion. Thereafter, the digest was mixed with 0.44 ml of 30% trichloroacetic acid and centrifuged at 2500 rpm for 10 min. The precipitate was washed with 0.5 ml of 5% trichloroacetic acid. The combined supernatant obtained from the trichloroacetic acid precipitation was extracted with ether, and the aqueous phase was neutralized with 1 M Na2CO3. Then the sample was applied to a Bio-Gel P-10 column (1.6 × 95 cm) using 1 M NaCl, 10% ethanol as the eluent. Eluates were monitored by absorbance at 210 nm, which is attributable mainly to carbonyl groups. Fractions I-IX were separately pooled as indicated in Fig. 2, concentrated, desalted through a column (1.5 × 46 cm) of Sephadex G-25 (fine) using distilled water as the eluent, and lyophilized. In this study, the smallest size fraction, fraction IX, was subfractionated into fractions a-v as indicated in Fig. 3 by HPLC. HPLC was performed in an LC-10AS system (Shimadzu Co., Kyoto, Japan) using a linear NaH2PO4 gradient from 16 to 798 mM over a 60-min period at a flow rate of 1.0 ml/min at room temperature (50). The eluates were monitored by absorbance at 210 nm. Each peak was purified by rechromatography under the same conditions as the first step and desalted as described above. Each peak was quantified by the carbazole method, using GlcA as a standard (49).


Fig. 2. Gel filtration column chromatography of the hyaluronidase digest of squid cartilage CS-E on Bio-Gel P-10. A commercial squid cartilage CS-E preparation was exhaustively digested with sheep testicular hyaluronidase as described under "Experimental Procedures." The digest was fractionated on a Bio-Gel P-10 column (1.6 × 95 cm) using 1 M NaCl, 10% ethanol as the eluent. Fractions (2 ml) were monitored by absorbance at 210 nm, and separated fractions were pooled as indicated.
[View Larger Version of this Image (24K GIF file)]


Fig. 3. Subfractionation of the tetrasaccharide fraction by HPLC on an amine-bound silica column. The tetrasaccharide fraction obtained by size fractionation (Fig. 2) was chromatographed on an amine-bound silica PA03 column using a linear salt gradient, as indicated by the dashed line. The bars at the top indicate the elution positions of the following authentic sulfated tetrasaccharides prepared by hyaluronidase digestion of shark cartilage CS-D (41) and king crab cartilage CS-K (44): 1, GlcAbeta 1-3GalNAc(6S)beta 1-4GlcAbeta 1-3GalNAc(6S); 2, GlcAbeta 1-3GalNAc(4S)beta 1-4GlcAbeta 1-3GalNAc(4S); 3, GlcAbeta 1-3GalNAc(6S)beta 1-4GlcAbeta 1-3GalNAc(4S); 4, GlcA(2S)beta 1-3GalNAc(6S)beta 1-4GlcAbeta 1-3GalNAc(6S); 5, GlcAbeta 1-3GalNAc(4S)beta 1-4GlcA(2S)beta 1-3GalNAc(6S); 6, GlcA(3S)beta 1-3GalNAc(4S)beta 1-4GlcAbeta 1-3GalNAc(4S); 7, GlcA(2S)beta 1-3GalNAc(6S)beta 1-4GlcAbeta 1-3GalNAc(4S); 8, GlcAbeta 1-3GalNAc(4S)beta 1-4GlcA(3S)beta 1-3GalNAc(4S); 9, GlcA(3S)beta 1-3GalNAc(4S)beta 1-4GlcA(3S)beta 1-3GalNAc(4S). Fractions marked by asterisks were subjected to structural analysis.
[View Larger Version of this Image (19K GIF file)]

Digestion of the Isolated Oligosaccharides with Chondroitinase ABC or AC-II

Each isolated oligosaccharide (1 nmol as GlcA) was digested using 5 mIU of chondroitinase AC-II or 10 mIU of chondroitinase ABC as described (39). Reactions were terminated by boiling for 1 min, and the reaction mixture was analyzed by capillary electrophoresis after derivatization with AMAC as described below.

CE Analysis of Underivatized Oligosaccharides and the AMAC Derivatives

The homogeneity of each purified oligosaccharide fraction was judged by CE (53) as well as by HPLC. For derivatization of oligosaccharide fractions, samples (1 nmol each) were first digested with chondroitinase AC-II as described above and concentrated to dryness in a vacuum concentrator. Then the digests were derivatized with AMAC according to Jackson (54). The labeled disaccharides were analyzed by CE according to the method of Kitagawa et al. (55). The electrophoresed fractions of the underivatized oligosaccharides and the AMAC derivatives were detected by absorption at 185 or 254 nm, respectively.

FAB-MS and 500-MHz 1H NMR Spectroscopy

The sugar and sulfate compositions of oligosaccharides were determined by FAB-MS. FAB mass spectra of the oligosaccharide samples were obtained using a VG Analytical ZAB-2SE 2FPD mass spectrometer fitted with a cesium ion gun operated at 20-25 kV. Data were acquired and processed using the VG Analytical Opus software. Monothioglycerol was used as the matrix. 1H NMR spectra of the oligosaccharides were measured on a Varian-500 at a probe temperature of 26 or 60 °C as reported (39, 41). Chemical shifts are given relative to sodium 4,4-dimethyl-4-silapentane-1-sulfonate but were actually measured indirectly, relative to acetone (delta 2.225) in 2H2O (56). Tetrasaccharides for NMR analysis were repeatedly exchanged in 2H2O with intermediate lyophilization.


RESULTS

The previous study on the GlcA(3S)-containing oligosaccharides isolated from king crab cartilage CS-K indicated that the disaccharide units containing GlcA(3S) were decomposed by the action of chondroitinase ABC (44) and that re-evaluation of disaccharide compositions was required for CS preparations that were purified from other biological sources and analyzed using the above enzyme. Therefore, in this study, various CS isoforms were first digested using chondroitinase ABC to compare the degree of unsaturated oligosaccharide formation from various CS isoforms.

Differential Susceptibility of Various CS Isoforms to Chondroitinase ABC

Various individual CS isoforms were digested with chondroitinase ABC, and the reactions were monitored by absorbance at 232 nm caused by Delta HexA produced by the eliminase action of the enzyme. The digestion degree was calculated based on the comparison of the amounts of the resultant unsaturated oligosaccharides estimated by the absorption at 232 nm and the uronic acid values determined for each parent CS isoform by the carbazole reaction. CS-A, -C, and -D yielded unsaturated products corresponding to 121, 118, and 121% of each parent isoform, respectively (Fig. 1). The apparent overproduction of the products was most likely due to the use of the average millimolar absorption coefficient (5.5) to calculate the unsaturated products. In contrast, the digestion of king crab cartilage CS-K produced unsaturated oligosaccharides corresponding to only 46% of the uronic acid contained in the parent polymer, consistent with the recent finding that GlcA(3S)-containing disaccharide units produced were destroyed by the enzymatic action and undetectable when monitored by absorbance at 232 nm (44). The production of UV-absorbing materials from squid cartilage CS-E reached 90% of the level calculated based on the uronic acid content but was significantly lower when compared with that of CS-A, CS-C, or CS-D. The disaccharide composition analysis by HPLC of the digest showed Delta HexAalpha 1-3GalNAc, Delta HexAalpha 1-3GalNAc(4S), Delta HexAalpha 1-3GalNAc(6S), and Delta HexAalpha 1-3GalNAc(4S,6S) in a molar ratio of 8.8:21.1:8.6:61.5. No other components were detected by absorbance at 232 nm. The findings may indicate that CS-E also contained the GlcA(3S) structure that was destroyed by the chondroitinase ABC treatment as in the case of CS-K. Therefore, squid cartilage CS-E was digested by hyaluronidase to obtain oligosaccharide fragments for structural analysis as below.

Preparation and Isolation of Tetrasaccharides

A commercial preparation of squid cartilage CS-E was exhaustively digested with sheep testicular hyaluronidase. Although the previous study demonstrated that CS-E as well as CS-D were less susceptible to testicular hyaluronidase when compared with CS-K and CS-A, it was digested to a significant degree (44). The digest was size-fractionated by gel filtration on a Bio-Gel P-10 column. A number of peaks were observed when monitored by absorbance at 210 nm that were caused primarily by carbonyl groups, and they were divided into nine fractions, I-IX, as indicated in Fig. 2. The large peak around fraction number 85 was attributable to the buffer salts. The elution profile was markedly different from that reported for king crab CS-K (44) and that for a commercial CS-D preparation (41), reflecting the differential susceptibility of the CS isoforms to the enzyme probably due to the linkage specificity of the enzyme. There were no fragments larger than octasaccharides among the CS-K degradation products, and there were small proportions of fragments larger than hexasaccharides among the CS-D degradation products. In contrast, larger oligosaccharides were predominant among the CS-E degradation products as shown in Fig. 2, being consistent with the relative unsusceptibility of CS-E to the hyaluronidase action (see Fig. 1 in Ref. 44). In this study, the smallest size fraction, fraction IX, was investigated. It represented approximately 6.4% of the resultant oligosaccharides and was judged to contain tetrasaccharides based on the well defined mechanism of action of hyaluronidase (57, 58). It was subfractionated into fractions a-v as indicated in Fig. 3 by HPLC on an amine-bound silica column. Five major fractions h, l, m, n, and q, marked by asterisks, were further purified by rechromatography to apparent homogeneity as judged by HPLC and CE (data not shown). Then their structures were analyzed as described below. As shown in Fig. 3, fraction h was eluted at the position of an authentic disulfated saturated tetrasaccharide GlcAbeta 1-3GalNAc(4S)beta 1-4GlcAbeta 1-3GalNAc (4S). Fractions l, m, and n were eluted at the positions of authentic saturated tetrasaccharides with three sulfate groups, whereas fraction q was eluted at the position of those with three or four sulfate groups. The elution position of fraction l was shortly after that of authentic GlcAbeta 1-3GalNAc(4S)beta 1-4GlcA(2S)beta 1-3GalNAc(6S), and that of fraction m was the same as that of authentic GlcA(3S)beta 1-3GalNAc(4S)beta 1-4GlcAbeta 1-3GalNAc(4S) or GlcA(2S)beta 1-3GalNAc(6S)beta 1-4GlcAbeta 1-3GalNAc(4S). The amounts of the purified oligosaccharides in fractions h, l, m, n, and q from 100 mg of CS-E are summarized in Table I together with the FAB-MS data.

Table I. FAB-MS analysis of the five oligosaccharides isolated from CS-E of squid cartilage


Fraction Yielda m/z for [M + Na - 2H]- m/z for [M + 2Na - 3H]- m/z for [M + 3Na - 4H]- m/z for [M + 4Na - 5H]- m/z for [M + 5Na - 6H]- Assignment

nmol
h 720 957 979 1001 HexA2HexNAc2(OSO3H)2
l 280 1059 1081 1103 HexA2HexNAc2(OSO3H)3
m 710 1037 1059 1081 1103 HexA2HexNAc2(OSO3H)3
n 530 1037 1059 1081 HexA2HexNAc2(OSO3H)3
q 930 1161 1183 1205 HexA2HexNAc2(OSO3H)4

a Yield is given in nmol obtained from 100 mg of CS-E.

FAB-MS Analysis

FAB-MS analyses of the underivatized oligosaccharide samples in the negative ion mode defined their molecular weights, from which the composition and the maximum number of O-sulfate groups present in each fraction were inferred, as in the case of heparin, heparan sulfate, and CS-K oligosaccharides (44, 53, 59). In the negative ion mode FAB spectrum, alkali-metal-attached molecular ions of the type [M + xNa - (x + 1)H]- (M represents the fully protonated acid forms of oligosaccharides) were preferentially observed. Representative FAB spectra are shown in Fig. 4, and assignments of the molecular ion signals afforded by each of the analyzed fractions are summarized in Table I.


Fig. 4. Negative ion mode FAB mass spectra of underivatized fractions n (A) and q (B). Major molecular ion signals were assigned as summarized in Table I.
[View Larger Version of this Image (64K GIF file)]

The molecular ion signal clusters at m/z 1037, 1059, and 1081 afforded by fraction n corresponded, respectively, to [M + Na - 2H]-, [M + 2Na - 3H]- and [M + 3Na - 4H]- of a trisulfated saturated tetrasaccharide HexA2HexNAc2 (OSO3H)3 (Fig. 4A). The molecular ion signal clusters at m/z 1161, 1183, and 1205 afforded by fraction q corresponded, respectively, to [M + 3Na - 4H]-, [M + 4Na - 5H]-, and [M + 5Na - 6H]- of a tetrasulfated saturated tetrasaccharide, HexA2HexNAc2(OSO3H)4 (Fig. 4B). The molecular ion signal clusters at m/z 957, 979, and 1001 afforded by fraction h corresponded, respectively, to [M + Na - 2H]-, [M +2Na - 3H]-, and [M + 3Na - 4H]- of a disulfated saturated tetrasaccharide, HexA2HexNAc2(OSO3H)2 (Table I). The molecular ion signal clusters at m/z 1059, 1081, and 1103 afforded by fraction l corresponded, respectively, to [M + 2Na - 3H]-, [M + 3Na - 4H]-, and [M + 4Na - 5H]- of a trisulfated saturated tetrasaccharide HexA2HexNAc2(OSO3H)3 (Table I). The molecular ion signal clusters at m/z 1037, 1059, 1081, and 1103 afforded by fraction m corresponded, respectively, to [M + Na - 2H]-, [M + 2Na - 3H]-, [M + 3Na - 4H]-, and [M + 4Na - 5H]- of a trisulfated saturated tetrasaccharide, HexA2 HexNAc2(OSO3H)3 (Table I).

Enzymatic Analysis of the Oligosaccharide Fractions in Conjunction with CE

The disaccharide composition of the isolated tetrasaccharides was determined by our microanalytical procedure (55). The chondroitinase AC-II digest of each tetrasaccharide was labeled with the fluorophore, AMAC. Then disaccharides were analyzed by CE. Chondroitinase AC-II, which is a bacterial eliminase, should degrade a CS-tetrasaccharide to yield 1 mol each of an unsaturated disaccharide unit and a saturated disaccharide unit derived from the reducing and the nonreducing terminus, respectively. The high resolution CE quantitatively resolves each authentic unsaturated disaccharide and the corresponding saturated disaccharide with a sulfation profile identical to that of the former. Therefore, this procedure not only gives the disaccharide composition but also gives information about the sequential arrangement of disaccharide units in a given oligosaccharide sequence (43, 55).

CE analysis of the chondroitinase AC-II digest of fraction h after the AMAC derivatization demonstrated AMAC-derivatives of GlcAbeta 1-3GalNAc(4S) (Di-4S) and Delta HexAalpha 1-3GalNAc (4S) (Delta Di-4S) in a molar ratio of 0.90:1.00 (Fig. 5A). The molar ratio was determined using the integrated peak areas reported for each standard CS-disaccharide (55). The disaccharides, Di-4S and Delta Di-4S, which share the same sulfation profile and differ only in the nonreducing terminal uronic acid residues in terms of saturation or unsaturation, were distinctly separated as described. The saturated disaccharide unit Di-4S was derived from the nonreducing terminus, whereas the unsaturated disaccharide unit Delta Di-4S was derived from the reducing terminus. The internal uronic acid is GlcA but not IdceA, since the tetrasaccharide was digested by chondroitinase AC-II. Hence, the compound in fraction h has the disulfated tetrasaccharide structure GlcAbeta 1-3GalNAc(4S)beta 1-4GlcAbeta 1-3Gal NAc(4S).


Fig. 5. CE analysis of the AMAC derivatives of the chondroitinase AC-II digests of the isolated tetrasaccharide fractions. The purified tetrasaccharide fractions h, l, m, n, or q, corresponding to 1 nmol, were each digested with chondroitinase AC-II, derivatized with AMAC, and analyzed by CE. (A, fraction h; B, fraction l; C, fraction m; D, fraction n; E, fraction q). Fractions were monitored by absorbance at 254 nm with AMAC. The elution positions of the authentic unsaturated CS disaccharides are indicated in the top panel. The peaks marked by asterisks are attributable to a reagent.
[View Larger Version of this Image (22K GIF file)]

CE analysis of the chondroitinase AC-II digest of fraction n after the AMAC derivatization showed AMAC derivatives of GlcAbeta 1-3GalNAc(4S,6S) (Di-diSE) and Delta Di-4S in a molar ratio of 1.20:1.00 (Fig. 5D), the former being derived from the nonreducing terminus and the latter from the reducing terminus. Hence, the major compound in fraction n has the hexasaccharide structure GlcAbeta 1-3GalNAc(4S,6S)beta 1-4GlcAbeta 1-3GalNAc (4S).

CE analysis of the chondroitinase AC-II digest of fraction l after AMAC derivatization showed AMAC derivatives of Delta Di-4S and an unidentified component X in a peak area ratio of 1.00:0.63, respectively (Fig. 5B). Likewise, fraction m resulted in AMAC derivatives of Delta Di-4S and an unidentified component Y in a peak area ratio of 1.00:0.64, and fraction q yielded AMAC derivatives of Delta Di-4S and an unidentified component Z in a peak area ratio of 1.00:0.68. The unidentified components X and Y migrated to the positions of AMAC derivatives of disulfated disaccharide units, whereas the component Z migrated to the position of an AMAC derivative of a trisulfated disaccharide unit. The results indicated that the compounds in fractions l, m, and q share the disaccharide unit GlcAbeta 1-3GalNAc(4S) on the reducing sides but differ in the disaccharide structures on the nonreducing sides. The smaller peak areas of the unidentified peaks compared with that of Delta Di-4S are probably due to the structural differences between Delta Di-4S and the unidentified compounds. However, the structure determination of the compound was not possible due to the lack of authentic compounds and had to await 1H NMR analysis as described below.

500-MHz 1H NMR Analysis

Each isolated tetrasaccharide fraction was characterized by 500-MHz 1H NMR spectroscopy. The sites of sulfation and the types of the internal uronic acid residues were determined by 1H NMR analysis. The one-dimensional 1H NMR spectra of fractions l, n, and q and two-dimensional HOHAHA spectra of fractions l and q are depicted as representatives in Figs. 6 and 7, respectively. The chemical shifts were assigned by two-dimensional HOHAHA and correlation spectroscopy analyses (41, 60), and the NMR data are summarized in Table II. The resonances were well resolved in the structural-reporter group regions between 4.4 and 5.3 ppm and at around 2.0 ppm, being separated from other signals in the bulk region (3.6-4.3 ppm). The resonances between 4.4 and 5.3 ppm are characteristic of anomeric protons, whereas those at around 2.0 ppm are characteristic of the NAc protons of GalNAc. When recorded at 60 °C to suppress the disturbance by the HOD line, the weak resonances at around 4.8 ppm were recognizable in the one-dimensional spectra (Fig. 6), which are shown in the insets. The types of the two uronic acid residues in each isolated tetrasaccharide were identified as GlcA based on the chemical shifts (delta  4.46-4.59) of the anomeric proton signals. Anomeric proton signals of an alpha IdceA and a beta GlcA in oligosaccharides derived from DS and CS are observed at around delta  5.0-5.2 and 4.5-4.8, respectively (39, 40, 61, 62). Two NAc proton signals were observed for each tetrasaccharide component. They were assigned by comparison with those of CS oligosaccharides reported previously (39, 41, 60).


Fig. 6. Structural-reporter group regions of the 500-MHz one-dimensional 1H NMR spectra of fractions l (A), n (B), and q (C) recorded in 2H2O at 26 °C. The numbers and letters in the spectra refer to the corresponding sugar residues in the structures. The insets are the spectra recorded at 60 °C to suppress disturbance by the HOD line. U and G represent GlcA and GalNAc, respectively.
[View Larger Version of this Image (34K GIF file)]


Fig. 7. Two-dimensional HOHAHA spectra of fractions l (A) and q (B) recorded in 2H2O. The numbers and letters in the spectra refer to the corresponding sugar residues in the structures. The spectrum of fraction l was recorded at 26 °C, whereas that of fraction q was recorded at 60 °C to suppress disturbance by the HOD line. U and G represent GlcA and GalNAc, respectively.
[View Larger Version of this Image (24K GIF file)]

Table II. 1H chemical shifts of the constituent monosaccharides of the tetrasaccharides isolated from CS-E

Chemical shifts are given in ppm downfield from internal sodium 4,4-dimethyl-4-silapentane-1-sulfonate but were actually measured indirectly in reference to acetone (delta  2.225 ppm) in 2H2O at 26 °C. The estimated error for the values to two decimal places was only ± 0.01 ppm because of partial overlap of signals. That for the values to three decimal places was ± 0.002 ppm.

Fraction h     U-G-U-Ga         |    |      4S    4S
Fraction l 6S    |     U-G-U-G         |        |      3S     4S
Fraction m     U-G-U-G         | |   |          3S 4S    4S
Fraction n 6S    |   U-G-U-G    |    |   4S    4S
Fraction q 6S   |   U-G-U-G | |  |  3S 4S    4S 
 alpha  beta  alpha  beta  alpha  beta  alpha  beta  alpha  beta

GalNAc-1
  H-1 5.209 4.718b 5.210 4.727b 5.210 4.73b 5.212 4.722b 5.211 4.717
  H-2 4.327 4.026 4.326 4.018 4.333 4.027 4.329 4.030 4.329 4.032
  H-3 4.183 ND 4.189 4.044b 4.183 ND 4.191 4.05 4.196 4.048b
  H-4 4.806b 4.734b 4.813b 4.738b 4.816b 4.746b 4.81b 4.74b 4.806b 4.733b
  H-5 4.253 NDc 4.244 ND 4.25 ND 4.25 ND 4.258 ND
  H-6 3.770 ND 3.788 ND 3.778 ND 3.788 ND 3.783 ND
  H-6' 3.713 ND 3.713 ND 3.715 ND 3.708 ND 3.702 ND
  NAc 2.022 2.020 2.024 2.021 2.021
GlcA-2
  H-1 4.520 4.475 4.529 4.484 4.540 4.492 4.538 4.492 4.539 4.494
  H-2 3.393 3.396 3.410 3.414 3.398 3.400 3.411 3.417 3.412 3.417
  H-3 3.583 3.594 3.601 3.607 3.608
  H-4 3.784 3.748 3.803 3.753 3.773
  H-5 3.664 3.67 ND 3.67 3.69
GalNAc-3
  H-1 4.571 4.560 4.58 4.624 4.624
  H-2 4.043 4.032 4.044 4.081 4.081
  H-3 4.05 3.837 4.053 4.09 4.09
  H-4 4.793b 4.224 4.798b 4.840b 4.826b
  H-5 ND 3.970 ND 4.133 4.130
  H-6 ND 4.22 ND 4.283 4.279
  H-6' ND 4.22 ND 4.230 4.230
  NAc 2.042 2.020 2.040 2.039 2.043
GlcA-4
  H-1 4.464 4.588 4.567 4.470 4.553
  H-2 3.339 3.483 3.505 3.345 3.497
  H-3 3.465 4.283 4.289 3.469 4.286
  H-4 3.524 3.652 3.752 3.525 3.70
  H-5 3.645 3.76 ND 3.653 ND

a G, U, 3S, 4S, and 6S represent GalNAc, GlcA, 3-O-sulfate, 4-O-sulfate, and 6-O-sulfate, respectively.
b Values determined at 60 °C.
c ND, not determined.

The one-dimensional spectrum (not shown) of fraction h was recorded at 26 °C and was identical with those reported previously for the disulfated tetrasaccharide GlcAbeta 1-3GalNAc (4S)beta 1-4GlcAbeta 1-3GalNAc(4S) isolated from shark cartilage CS-D (fraction 2 in Ref. 41). The NMR data are summarized in Table II together with those of the other fractions. Thus, the structure of the compound in fraction h is as follows, consistent with the results from the enzymatic analysis.
<UP>GlcA&bgr;1–3GalNAc</UP>(<UP>4S</UP>)<UP>&bgr;1–4GlcA&bgr;1–3GalNAc</UP>(<UP>4S</UP>)
<UP><SC>Structure</SC> 1.
<B>Fraction </B></UP><B><IT>h</IT><UP>.</UP></B>
The one-dimensional 1H NMR spectrum (not shown) of fraction m was indistinguishable from that of the trisulfated tetrasaccharide GlcA(3S)beta 1-3GalNAc(4S)beta 1-4GlcAbeta 1-3GalNAc (4S) isolated from king crab cartilage CS-K (fraction 2 in Ref. 44). The NMR data are summarized in Table II. Thus, the structure of the compound in fraction m is as follows.
<UP>GlcA</UP>(<UP>3S</UP>)<UP>&bgr;1–3GalNAc</UP>(<UP>4S</UP>)<UP>&bgr;1–4GlcA&bgr;1–3GalNAc</UP>(<UP>4S</UP>)
<UP><SC>Structure</SC> 2.
<B>Fraction </B></UP><B><IT>m</IT><UP>.</UP></B>
Comparison of the spectral data of fraction n with those of the previously reported structures revealed that this fraction contains a saturated counterpart of the unsaturated trisulfated tetrasaccharide Delta HexAalpha 1-3GalNAc(4S,6S)beta 1-4GlcAbeta 1-3Gal NAc(4S) isolated from squid cartilage CS-E after chondroitinase ABC digestion (fraction 9 in Ref. 39). The chemical shifts of protons belonging to the nonreducing uronic acid residue were very similar to those of the saturated tetrasaccharides isolated from shark cartilage CS-D (fraction 3 in Ref. 41) and king crab cartilage CS-K (44), indicating the presence of a saturated GlcA residue (GlcA-4) at the nonreducing end. Large downfield shifts of GalNAc-1 H-4 and GalNAc-3 H-4, H-6, and H-6' were observed when compared with those of the nonsulfated GalNAc residues found in CS oligosaccharides (60, 63), supporting 4-O-sulfation of GalNAc-1 and 4,6-O-disulfation of GalNAc-3 in agreement with the trisulfated tetrasaccharide composition proposed by FAB-MS. Therefore, the following structure of the compound in fraction n is in good agreement with the results obtained from the enzymatic analysis described above.
<UP>GlcA&bgr;1–3GalNAc</UP>(<UP>4S,6S</UP>)<UP>&bgr;1–4GlcA&bgr;1–3GalNAc</UP>(<UP>4S</UP>)
<UP><SC>Structure</SC> 3.
<B>Fraction </B></UP><B><IT>n</IT><UP>.</UP></B>
The results from FAB-MS and the enzymatic analysis indicated that the compound in fraction l is a trisulfated tetrasaccharide composed of a GlcAbeta 1-3GalNAc(4S) unit on the reducing side and a GlcAbeta 1-3GalNAc unit with two sulfate groups on the nonreducing side, namely (GlcAbeta 1-3GalNAc)(disulfate) beta 1-4GlcAbeta 1-3GalNAc(4S). The one- and two-dimensional 1H NMR spectra of fraction l are presented in Figs. 6A and 7A, respectively. Compared with the spectral data of the disulfated tetrasaccharide GlcAbeta 1-3GalNAc(6S)beta 1-4GlcAbeta 1-3GalNAc(4S) isolated from shark cartilage CS-D (fraction 3 in Ref. 41), no significant differences were observed except for the downfield shifts of H-1, H-2, and H-3 of GlcA-4 by Delta 0.09, 0.17, and 0.82 ppm, respectively. This indicates that the compound in this fraction is a tetrasaccharide composed of the above trisaccharide sequence (-3GalNAc(6S)beta 1-4GlcAbeta 1-3GalNAc(4S)) on the reducing side and a 3-O-sulfated GlcA at the nonreducing terminus (44). These results are consistent with the m/z value obtained by FAB-MS and those from the enzymatic analysis described above. Thus, the compound in fraction l has the following structure.
<UP>GlcA</UP>(<UP>3S</UP>)<UP>&bgr;1–3GalNAc</UP>(<UP>6S</UP>)<UP>&bgr;1–4GlcA&bgr;1–3GalNAc</UP>(<UP>4S</UP>)
<UP><SC>Structure</SC> 4.
<B>Fraction </B></UP><B><IT>l</IT><UP>.</UP></B>
The one- and two-dimensional 1H NMR spectra of fraction q are shown in Figs. 6C and 7B, respectively. In the one-dimensional spectrum, the chemical shifts of protons belonging to GalNAc-1 and GlcA-2 were very similar to those of the compound in fraction l, indicating the presence of the monosulfated disaccharide sequence of -4GlcAbeta 1-3GalNAc(4S). Compared with the NMR data for fraction l (Table II), no significant differences were observed except for the downfield shifts of H-3, H-4, and H-5 of GalNAc-3 by Delta 0.25, 0.60, and 0.16 ppm, respectively. This indicates that the compound in fraction q has the structure with an additional sulfate group on C4 of GalNAc-3 in the structure proposed for the compound in fraction l. These results are consistent with the m/z value obtained by FAB-MS and the enzymatic analysis described above. Thus, the compound in fraction q has the following structure.
<UP>GlcA</UP>(<UP>3S</UP>)<UP>&bgr;1–3GalNAc</UP>(<UP>4S,6S</UP>)<UP>&bgr;1–4GlcA&bgr;1–3GalNAc</UP>(<UP>4S</UP>)
<UP><SC>Structure</SC> 5.
<B>Fraction </B></UP><B><IT>q</IT><UP>.</UP></B>
Two NAc proton signals were observed for each oligosaccharide component except for fraction l, which gave a single signal at delta  2.020. They were assigned by comparison with those of the reported CS oligosaccharides (39, 41, 42, 60). In a previous 1H NMR study of saturated CS tetrasaccharides (41, 44), the chemical shifts of the NAc proton signals of GalNAc(4S)-1 and GalNAc(4S)-3 were observed around delta  2.018-2.023 and delta  2.041-2.044, respectively, and were influenced by O-sulfation of the neighboring uronic acid residue (39, 41, 60). Based on these observations, the NAc proton signals of the tetrasaccharides in the isolated fractions were assigned as shown in Table II. The NAc proton signals of GalNAc-1 were observed at a higher magnetic field than those of GalNAc-3.


DISCUSSION

In this study, CS-E tetrasaccharides were prepared by testicular hyaluronidase digestion, which exhibits transglycosylation activity through the reverse reaction of hydrolysis (64, 65). However, since disaccharides do not serve as acceptors, the isolated tetrasaccharides most likely originated from the natural sequences as has been noted (43). The possibility that they were released from higher oligo- or polysaccharide chains newly formed by transglycosylation reactions is unlikely, due to the low concentrations of such chains. Indeed, the structures of the tetra- and hexasaccharides prepared by hyaluronidase digestion of CS-D (41, 43) were in agreement with those of the oligosaccharides prepared by chondroitinase digestion (39, 42). The structures of the isolated tetrasaccharides strongly indicate that the enzyme preferentially cleaves the N-acetylgalactosaminidic linkage in sequences containing GalNAc(4S)beta 1-4GlcAbeta 1-3GalNAc and GalNAc(4S)beta 1-4GlcA(3S)beta 1-3GalNAc but not that in the GalNAc(4S,6S)beta 1-4GlcA sequence. The susceptibility of the N-acetylgalactosaminidic linkage to GlcA(3S) has been observed for king crab CS-K that contains a high proportion of GlcA(3S) and is extensively digested into small oligosaccharides (44). This markedly contrasts the insusceptibility of this linkage to chondroitinase AC-II and to the decomposition of GlcA(3S) residues upon chondroitinase ABC treatment (44, 45). The elution profile observed in Fig. 2 probably reflects the CS-E structure that contains a high content (61%) of GalNAc(4S,6S)beta 1-4GlcA units (46) resistant to the hyaluronidase action.

The isolated tetrasaccharides in fractions h and m as well as an unsaturated counterpart of that in fraction n have been reported (39, 41, 44), whereas those in fractions l and q are novel in that they contain GlcA(3S) directly linked to GalNAc(6S) and GalNAc(4S,6S) forming unusual disaccharide units GlcA(3S)beta 1-3GalNAc(6S) and GlcA(3S)beta 1-3GalNAc (4S,6S), respectively. These disaccharide structures have been suggested for oversulfated CS isolated from squid skin (66-68) as will be discussed below. The present study demonstrated their structures in the novel tetrasaccharide sequences. Thus, the GlcA(3S)-containing structure in squid cartilage CS-E seems to have been missed in previous studies where a disaccharide composition analysis was performed by chondroitinase ABC digestion (11, 39, 46). The lower recovery of unsaturated oligosaccharide products from the chondroitinase ABC digest (Fig. 1) seems to indicate the probable decomposition of the GlcA(3S)-containing disaccharide units. The GlcA(3S) content in the CS-E preparation may be roughly estimated to be up to 10% based on the recovery of unsaturated oligosaccharides. The structures of oversulfated CSs isolated from other biological sources, especially those containing GalNAc(4S,6S), should be reinvestigated to see if GlcA(3S) is contained.

Unique fucose-branched CS isolated from sea cucumber also contains GlcA(3S) (69) as well as a disaccharide unit GlcA-GalNAc(4S,6S) (70), although the sequential arrangement of these structural elements in the polysaccharide chain has not been reported. A proteoglycan bearing oversulfated CS chains has also been isolated from squid skin, and unsaturated counterparts of the disaccharide units (GlcA(2S)-GalNAc(6S), GlcA(3S)-GalNAc(4S) and GlcA-GalNAc(4S,6S)) as well as the GlcA(3S)-containing trisulfated disaccharide unit have been noted (66, 67). The proposal of the GlcA(3S)-containing structure for the disulfated and the trisulfated units was based on the elution positions on HPLC, the reactivity to the HNK-1 antibody, and the resistance to periodate oxidation. However, there is an apparent discrepancy between our findings and the isolation procedures used in the above studies. Karamanos et al. (67, 68) have reported that the GlcA(3S)-containing disaccharide units were obtained by digestion of squid skin CS with chondroitinase AC (presumably AC-II as in Karamanos et al. (71) although not specified), which strikingly contrasts to the findings by us and others that such structures were resistant to this particular enzyme (44, 45, 69). We could obtain GlcA(3S)-containing oligosaccharides only by hyaluronidase digestion (12, 44, 45). This discrepancy remains to be clarified.

The structures found in fractions l and q are hybrids. The compound in fraction l contained structural elements for CS-A (GalNAc(4S)), CS-C (GalNAc(6S)), and CS-K (GlcA(3S)) in a single sequence, whereas that in fraction q contained elements for CS-A, CS-K, and CS-E (GalNAc(4S,6S)). A tetrasaccharide, Delta HexA-GalNAc(4S,6S)-GlcA(2S)-GalNAc(6S), with a hybrid structure of the CS-D and CS-E structural elements had been isolated from shark fin cartilage CS after chondroitinase AC-I digestion, taking advantage of the resistant nature of the GalNAc-GlcA(2S) to the enzyme (46). This finding and ours may indicate that various combinations of the structural units representative of different CS isoforms result in more domain structures than anticipated, which would be embedded in oversulfated CS chains. It should be emphasized that immunological studies using CS-specific monoclonal antibodies including MO-225 that interact specifically with this hybrid structure (46) revealed developmentally regulated expression of distinct CS epitopes during the odontogenesis in the mouse fetus (4). Thus, rare hybrid structural domains would be extremely unique so that they would specifically be recognized by other molecules and be involved in various biological processes. The structural bases for the in vitro activities of squid cartilage CS-E and for the physiological functions of mammalian CS-E/DS-E have to be reinvestigated in regard to the new structural feature demonstrated in this study. It remains to be clarified whether or not the novel sequences exist in chondroitin sulfate chains of mammalian origin and whether or not they have specific functions.

It is well known that GlcA(3S) is detected in a glycolipid isolated from human peripheral nerves using the mouse monoclonal antibody HNK-1, raised against human natural killer cells (72, 73). The terminal GlcA(3S) residue is essential for the immunoreactivity, and the carbohydrate epitope is expressed also on glycoproteins (74). The trisaccharide sequence GlcA(3S)beta 1-3Galbeta 1-4GlcNAc has been demonstrated for the epitope on bovine peripheral myelin glycoprotein P0 (75). The HNK-1-reactive carbohydrates are temporally and spatially regulated during the development of the nervous system (76) and implicated in cell-cell adhesion as well as in the recognition of neurons and astrocytes (77). In addition, the HNK-1-reactive carbohydrate is a ligand for selectins, which are leukocyte-endothelial cell adhesion molecules (78). It has been reported that the HNK-1 antibody reacted with an intact CS polymer from squid skin (67). It will be interesting to investigate whether GlcA(3S)-containing CS chains exist in the nervous system.

Biosynthetic mechanisms for the production of GlcA(3S) in oversulfated CSs or HNK-1 antigens are unknown. There may exist multiple 3-O-sulfotransferases, which synthesize CS-K, CS-E, and the GlcA(3S)-containing HNK-1 epitopes in glycolipids and glycoproteins, although none of them has been demonstrated. In contrast, two 6-O-sulfotransferases involved in the synthesis of GalNAc(4S,6S) have been reported. The one that synthesizes internal GalNAc(4S,6S) units was demonstrated in squid cartilage (79). The other 6-O-sulfotransferase that specifically transfers a sulfate group to the GalNAc(4S) residue at the nonreducing terminus to form GalNAc(4S,6S) was discovered in human serum (79, 80). GalNAc(4S,6S) has been found at the nonreducing terminus of the newly synthesized CS in the in vitro culture of chick and rat embryo cartilage (81, 82) and in the cell culture of chick chondrocytes and rat chondrosarcoma (17, 83) and is suggested as the possible chain termination signal in the CS biosynthesis. In the recent enzymological studies, sulfated CS tetra- or hexasaccharides with GlcAbeta 1-3GalNAc(4S,6S) or GlcA(3S)beta 1-3GalNAc(4S) at the nonreducing ends did not serve as acceptors for chondroitin GalNAc transferase (84), supporting the notion of the termination signal. Interestingly, CS-E but not CS-C synthesis in fetal calf articular cartilage in culture was stimulated by dibutyryl cyclic AMP, indicating specific control mechanisms for the CS-E biosynthesis (85). Regulatory mechanisms for the CS-E synthesizing system including the putative 3-O-sulfotransferase will be interesting to investigate.


FOOTNOTES

*   The work performed in Japan was supported in part by the Science Research Promotion Fund from the Japan Private School Promotion Foundation, Grants-in-aid for Exploratory Research 08877338, Scientific Research (B) 09558082, Scientific Research on Priority Areas 05274107, and International Scientific Research (Joint Research) 09044345 from the Ministry of Education and Culture of Japan. The work performed at Imperial College was supported by grants from the Biotechnology and Biological Sciences Research Council, the Medical Research Council, and the Wellcome Trust (to H. R. M. and A. D.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   To whom correspondence should be addressed. Tel.: 81-78-441-7570; Fax: 81-78-441-7569; E-mail: k-sugar{at}kobepharma-u.ac.jp.
1   The abbreviations used are: CS, chondroitin sulfate; AMAC, 2-aminoacridone; DS, dermatan sulfate; FAB-MS, fast atom bombardment-mass spectrometry; HOHAHA, homonuclear Hartmann-Hahn; Delta HexA, 4,5-unsaturated hexuronic acid or 4-deoxy-alpha -L-threo-hex-4-ene-pyranosyluronic acid; HexA, hexuronic acid; HexNAc, N-acetylhexosamine; HPLC, high performance liquid chromatography; Delta Di-6S, Delta 4,5HexAalpha 1-3GalNAc(6-O-sulfate); Delta Di-4S, Delta 4,5HexAalpha 1-3GalNAc(4-O-sulfate); Di-4S, GlcAbeta 1-3GalNAc(4-O-sulfate); Delta Di-diSD, Delta 4,5HexA(2-O-sulfate)alpha 1-3GalNAc(6-O-sulfate); Delta Di-diSE, Delta 4,5HexAalpha 1-3GalNAc(4, 6-O-disulfate); 2S, 3S, 4S, and 6S, 2-O-sulfate, 3-O-sulfate, 4-O-sulfate, and 6-O-sulfate, respectively.

ACKNOWLEDGEMENTS

We thank Tomoko Hazeki for technical assistance and Dr. Makiko Sugiura (Kobe Pharmaceutical University) for recording the NMR spectra.


REFERENCES

  1. Poole, A. R. (1986) Biochem. J. 236, 1-14 [Medline] [Order article via Infotrieve]
  2. Fransson, L. Å. (1987) Trends Biochem. Sci. 12, 406-411 [CrossRef]
  3. Ruoslahti, E. (1988) J. Biol. Chem. 264, 13369-13372 [Free Full Text]
  4. Mark, M. P., Baker, J. R., Kimata, K., and Ruch, J.-V. (1990) Int. J. Dev. Biol. 34, 191-204 [Medline] [Order article via Infotrieve]
  5. Lander, A. D. (1993) Curr. Opin. Nerobiol. 3, 716-723 [Medline] [Order article via Infotrieve]
  6. Sorrell, J. M., Mahmoodian, F., Schafer, I. A., Davis, B., and Caterson, B. (1990) J. Histochem. Cytochem. 38, 393-402 [Abstract]
  7. Soda, T., Egami, F., and Horigome, T. (1940) Nippon Kagaku Zasshi 61, 43-49
  8. Mathews, M. B., and Person, P. (1962) Nature 193, 378-379 [Medline] [Order article via Infotrieve]
  9. Mathews, M. B. (1966) Clin. Orthop. Relat. Res. 48, 267-283 [Medline] [Order article via Infotrieve]
  10. Suzuki, S. (1960) J. Biol. Chem. 235, 3580-3588
  11. Suzuki, S., Saito, H., Yamagata, T., Anno, K., Seno, N., Kawai, Y., and Furuhashi, T. (1968) J. Biol. Chem. 243, 1543-1550 [Abstract/Free Full Text]
  12. Seno, N., and Murakami, K. (1982) Carbohydr. Res. 103, 190-194
  13. Iwata, H. (1969) J. Jpn. Orthop. Assoc. 43, 455-473
  14. Anno, K., Seno, N., Mathews, M. B., Yamagata, T., and Suzuki, S. (1971) Biochim. Biophys. Acta 237, 173-177 [Medline] [Order article via Infotrieve]
  15. Gregoire, P. E., Dictus-Vermeulen, C., and Ameryckx, J. P. (1972) Biochim. Biophys. Acta 279, 102-117 [Medline] [Order article via Infotrieve]
  16. Yoshida, K., Miyauchi, S., Kikuchi, H., Tawada, A., and Tokuyasu, K. (1989) Anal. Biochem. 177, 327-332 [Medline] [Order article via Infotrieve]
  17. Kim, J. J., and Conrad, H. E. (1982) J. Biol. Chem. 257, 1670-1675 [Free Full Text]
  18. Otsu, K., Nakano, T., Kanakura, Y., Asai, H., Katz, H. R., Austen, K. F., Stevens, R. L., Galli, S. J., and Kitamura, Y. (1987) J. Exp. Res. 165, 615-627
  19. Davidson, S., Gilead, L., Amira, M., Ginsburg, H., and Razin, E. (1990) J. Biol. Chem. 265, 12324-12330 [Abstract/Free Full Text]
  20. Kolset, S. O., and Gallagher, J. T. (1990) Biochim. Biophys. Acta 1032, 191-211 [CrossRef][Medline] [Order article via Infotrieve]
  21. Yurt, R. W., Leid, R. W., Jr., Austen, K. F., and Silbert, J. E. (1977) J. Biol. Chem. 252, 518-521 [Abstract]
  22. Razin, E., Stevens, R. L., Akiyama, F., Schmid, K., and Austen, K. F. (1982) J. Biol. Chem. 257, 7229-7236 [Abstract/Free Full Text]
  23. Enerbäck, L., Kolset, S. D., Kusche, M., Hjerpe, A., and Lindahl, U. (1985) Biochem. J. 227, 661-668 [Medline] [Order article via Infotrieve]
  24. Eliakim, R., Gilead, L., Ligumsky, M., Okon, E., Rachmilewitz, D., and Razin, E. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 461-464 [Abstract]
  25. Stevens, R. L., Fox, C. C., Lichtenstein, L. M., and Austen, K. F. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 2284-2287 [Abstract]
  26. Rothenberg, M. E., Caulfield, J. P., Austen, K. F., Hein, A., Edmiston, K., Newburger, P. E., and Stevens, R. L. (1987) J. Immunol. 138, 2616-2625 [Abstract/Free Full Text]
  27. Serafin, W. E., Katz, H. R., Austen, K. F., and Stevens, R. L. (1986) J. Biol. Chem. 261, 15017-15021 [Abstract/Free Full Text]
  28. Takasu, Y., Hasumi, F., and Mori, Y. (1982) Biochim. Biophys. Acta 716, 316-323 [Medline] [Order article via Infotrieve]
  29. Kolset, S. O., Kjellén, L., Seljelid, R., and Lindahl, U. (1983) Biochem. J. 210, 661-667 [Medline] [Order article via Infotrieve]
  30. Kolset, S. O. (1986) Biochem. Biophys. Res. Commun. 139, 377-382 [Medline] [Order article via Infotrieve]
  31. Edwards, I. J., Xu, H., Obunike, J. C., Goldberg, I. J., and Wagner, W. D. (1995) Arterioscler. Thromb. Vasc. Biol. 15, 400-409 [Abstract/Free Full Text]
  32. Akiyama, F., Seno, N., and Yoshida, K. (1982) Tohoku J. Exp. Med. 136, 359-365 [Medline] [Order article via Infotrieve]
  33. Scully, M. F., Ellis, V., Seno, N., and Kakkar, V. V. (1986) Biochem. Biophys. Res. Commun. 137, 15-22 [Medline] [Order article via Infotrieve]
  34. Bourin, M-C., Lundgren-Åkerlund, E., and Lindahl, U. (1990) J. Biol. Chem. 265, 15424-15431 [Abstract/Free Full Text]
  35. Bourin, M-C., and Lindahl, U. (1993) Biochem. J. 289, 313-330 [Medline] [Order article via Infotrieve]
  36. McGee, M. P., Teuschler, H., Parthasarathy, N., and Wagner, W. D. (1995) J. Biol. Chem. 270, 26109-26115 [Abstract/Free Full Text]
  37. Wilson, J. G., Fearon, D. T., Stevens, R. L., Seno, N., and Austen, K. F. (1984) J. Immunol. 132, 3058-3063 [Abstract/Free Full Text]
  38. Hojima, Y., Cochrane, C. G., Wiggins, R. C., Austen, K. F., and Stevens, R. L. (1984) Blood 63, 1453-1459 [Abstract]
  39. Sugahara, K., Shigeno, K., Masuda, M., Fujii, N., Kurosaka, A., and Takeda, K. (1994) Carbohydr. Res. 255, 145-163 [CrossRef][Medline] [Order article via Infotrieve]
  40. Sugahara, K., Takemura, Y., Sugiura, M., Kohno, Y., Yoshida, K., Takeda, K., Khoo, K. H., Morris, H. R., and Dell, A. (1994) Carbohydr. Res. 255, 165-182 [CrossRef][Medline] [Order article via Infotrieve]
  41. Sugahara, K., Tanaka, Y., and Yamada, S. (1996) Glycoconjugate J. 13, 609-619 [Medline] [Order article via Infotrieve]
  42. Sugahara, K., Nadanaka, S., Takeda, K., and Kojima, T. (1996) Eur. J. Biochem. 239, 871-880 [Abstract]
  43. Nadanaka, S., and Sugahara, K. (1997) Glycobiology 7, 253-263 [Abstract]
  44. Sugahara, K., Tanaka, Y., Yamada, S., Seno, N., Kitagawa, H., Haslam, S. M., Morris, H. R., and Dell, A. (1996) J. Biol. Chem. 271, 26745-26754 [Abstract/Free Full Text]
  45. Kitagawa, H., Tanaka, Y., Yamada, S., Seno, N., Haslam, S. M., Morris, H. R., Dell, A., and Sugahara, K. (1997) Biochemistry 36, 3998-4008 [CrossRef][Medline] [Order article via Infotrieve]
  46. Yamagata, M., Kimata, K., Oike, Y., Tani, K., Maeda, N., Yoshida, K., Shinomura, Y., Yoneda, M., and Suzuki, S. (1987) J. Biol. Chem. 262, 4146-4152 [Abstract/Free Full Text]
  47. Sugahara, K., Kinoshita, A., Yamada, S., Haslam, S. M., Morris, H. R., and Dell, A. (1996) Abstract of the 18th International Carbohydrate Symposium, Milan, July 21-26, 1996, p. 40
  48. Seno, N., Yamashiro, S., and Anno, K. (1974) Biochim. Biophys. Acta 343, 423-426 [Medline] [Order article via Infotrieve]
  49. Bitter, M., and Muir, H. (1962) Anal. Biochem. 4, 330-334
  50. Sugahara, K., Okumura, Y., and Yamashina, I. (1989) Biochem. Biophys. Res. Commun. 162, 189-197 [Medline] [Order article via Infotrieve]
  51. Poh, C. H., Yuen, R., Chung, M. C. M., and Khoo, H. E. (1992) Comp. Biochem. Physiol. 101B, 159-163
  52. Sugahara, K., Yamada, S., Sugiura, M., Takeda, K., Yuen, R., Khoo, H. E., and Poh, C. H. (1992) Biochem. J. 283, 99-104 [Medline] [Order article via Infotrieve]
  53. Sugahara, K., Tohno-oka, R., Yamada, S., Khoo, K. H., Morris, H. R., and Dell, A. (1994) Glycobiology 4, 535-544 [Abstract]
  54. Jackson, P. (1991) Anal. Biochem. 196, 238-244 [Medline] [Order article via Infotrieve]
  55. Kitagawa, H., Kinoshita, A., and Sugahara, K. (1995) Anal. Biochem. 232, 114-121 [CrossRef][Medline] [Order article via Infotrieve]
  56. Vliegenthart, J. F. G., Dorland, L., and Van Halbeek, H. (1983) Adv. Carbohydr. Chem. Biochem. 41, 209-374
  57. Meyer, K. (1971) in Enzymes (Boyer, P. D., ed), Vol. 5, pp. 307-320, Academic Press, New York
  58. Kresse, H., and Glössl, J. (1987) Adv. Enzymol. Relat. Areas Mol. Biol. 60, 217-314 [Medline] [Order article via Infotrieve]
  59. Yamada, S., Sakamoto, K., Tsuda, H., Yoshida, K., Sugahara, K., Khoo, K. H., Morris, H. R., and Dell, A. (1994) Glycobiology 4, 69-78 [Abstract]
  60. Yamada, S., Yoshida, K., Sugiura, M., and Sugahara, K. (1992) J. Biochem. (Tokyo) 112, 440-447 [Abstract]
  61. Sugahara, K., Ohkita, Y., Shibata, Y., Yoshida, K., and Ikegami, A. (1995) J. Biol. Chem. 270, 7204-7212 [Abstract/Free Full Text]
  62. Goto, F., and Ogawa, T. (1994) Bioorg. Med. Chem. Lett. 4, 619-624 [CrossRef]
  63. Sugahara, K., Yamashina, I., De Waard, P., Van Halbeek, H., and Vliegenthart, J. F. G. (1988) J. Biol. Chem. 263, 10168-10174 [Abstract/Free Full Text]
  64. Weissman, B. (1955) J. Biol. Chem. 216, 783-794 [Free Full Text]
  65. Highsmith, S., Garvin, J. H., Jr., and Chipman, D. M. (1975) J. Biol. Chem. 250, 7473-7480 [Abstract]
  66. Karamanos, N. K., Aletras, A. J., Tsegenidis, T., Tsiganos, C. P., and Antonopoulos, C. A. (1992) Eur. J. Biochem. 204, 553-560 [Abstract]
  67. Karamanos, N. K., Aletras, A. J., Antonopoulos, C. A., and Hjerpe, A. (1994) Biochimie 76, 79-82 [Medline] [Order article via Infotrieve]
  68. Karamanos, N. K., Syrokou, A., Vanky, P., Nurminen, M., and Hjerpe, A. (1994) Anal. Biochem. 221, 189-199 [CrossRef][Medline] [Order article via Infotrieve]
  69. Vieira, R. P., Mulloy, B., and Mourão, P. A. S. (1991) J. Biol. Chem. 266, 13530-13536 [Abstract/Free Full Text]
  70. Kariya, Y., Watabe, S., Hashimoto, K., and Yoshida, K. (1990) J. Biol. Chem. 265, 5081-5085 [Abstract/Free Full Text]
  71. Karamanos, N. K., Hjerpe, A., Aletras, A. J., Tsegenidis, T., Anastassiou, E. D., and Antonopoulos, C. A. (1995) Arch. Biochem. Biophys. 316, 100-109 [CrossRef][Medline] [Order article via Infotrieve]
  72. Di Ferrante, N. (1956) J. Biol. Chem. 220, 303-306 [Free Full Text]
  73. Ariga, T., Kohriyama, T., Freddo, L., Latov, N., Saito, M., Kon, K., Ando, S., Suzuki, M., Hemling, M. E., Rinehart, K. L., Jr., Kusunoki, S., and Yu, R. K. (1987) J. Biol. Chem. 262, 848-853 [Abstract/Free Full Text]
  74. Ilyas, A. A., Dalakas, M. C., Brady, R. O., and Quarles, R. H. (1986) Brain Res. 385, 1-9 [CrossRef][Medline] [Order article via Infotrieve]
  75. Voshol, H., van Zuylen, C. W. E. M., Orberger, G., Vliegenthart, J. F. G., and Schachner, M. (1996) J. Biol. Chem. 271, 22957-22960 [Abstract/Free Full Text]
  76. Chou, D. K. H., Prasadarao, N., Koul, O., and Jungalwala, F. B. (1991) J. Neurochem. 57, 852-859 [Medline] [Order article via Infotrieve]
  77. Künemund, V., Jungalwala, F. B., Fischer, G., Chou, D. K. H., Keilhauer, G., and Schachner, M. (1988) J. Cell Biol. 106, 213-223 [Abstract]
  78. Needham, L. K., and Schnaar, R. L. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 1359-1363 [Abstract]
  79. Habuchi, O., Yamagata, T., and Suzuki, S. (1971) J. Biol. Chem. 246, 7357-7365 [Abstract/Free Full Text]
  80. Inoue, H., Otsu, K., Yoneda, M., Kimata, K., Suzuki, S., and Nakanishi, Y. (1986) J. Biol. Chem. 261, 4460-4469 [Abstract/Free Full Text]
  81. Tsuji, M., Nakanishi, Y., Habuchi, H., Ishihara, K., and Suzuki, S. (1980) Biochim. Biophys. Acta 612, 373-383 [Medline] [Order article via Infotrieve]
  82. Otsu, K., Inoue, H., Tsuzuki, Y., Yonekura, H., Nakanishi, Y., and Suzuki, S. (1985) Biochem. J. 227, 37-48 [Medline] [Order article via Infotrieve]
  83. Midura, R. J., Calabro, A., Yanagishita, M., and Hascall, V. C. (1995) J. Biol. Chem. 270, 8009-8015 [Abstract/Free Full Text]
  84. Kitagawa, H., Tsutsumi, K., Ujikawa, M., Goto, F., Tamura, J., Neumann, K. W., Ogawa, T., and Sugahara, K. (1997) Glycobiology 7, 531-537 [Abstract]
  85. Speight, G., Handley, C. J., and Lowther, D. A. (1981) Biochim. Biophys. Acta 672, 89-97 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.